e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients
Jana Kleinerova, Patricia Ging, Colin Rutherford, Iain Lawrie, Sara Winward, Donna Eaton, Karen C. Redmond, Jim J. Egan
Source:
Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jana Kleinerova, Patricia Ging, Colin Rutherford, Iain Lawrie, Sara Winward, Donna Eaton, Karen C. Redmond, Jim J. Egan. The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients. Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation
Source: Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017
Year: 2017
Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Outcomes and survival in alpha1-antitrypsin deficiency post lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Homecare setting of longterm augmentation therapy in alpha1 antitrypsin defiency patients leads to clinical stabilization
Source: International Congress 2017 – New frontiers in home care management of chronic lung diseases
Year: 2017
The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Year: 2018
Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports
Source: Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019
Year: 2020
Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009
Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept